Patients who receive more cells get significant benefits. That’s a key lesson emerging from a clinical trial that was reported at the American Heart Association meeting in Chicago. In this study, doctors treated heart attack patients with their own bone marrow cells, selected for their healing potential and then reinjected into the heart, in an effort to improve the heart’s recovery. In the PreSERVE-AMI phase II … Continue reading Dosage determined in landmark human study of stem cell therapy for heart attack.